DR. ARSHDEEP  SINGH

DR. ARSHDEEP SINGH

ASSOCIATE PROFESSOR


Medical Gastroenterology
MBBS, MD (Medicine), DM (Gastroenterology)
PMC-40607

About Doctor

Dr. Arshdeep Singh is a dedicated gastroenterologist with a special focus on Inflammatory Bowel Disease (IBD), including ulcerative colitis and Crohn’s disease. He is known for his patient-centered approach, combining advanced diagnostics, personalized treatment plans, and evidence-based care. His clinical expertise also spans liver diseases, pancreatobiliary disorders, and therapeutic endoscopy. Dr. Singh is actively involved in research, education, and clinical innovation, with numerous national and international presentations and publications. He is committed to improving long-term outcomes through preventive gastroenterology, multidisciplinary care, and active patient engagement. His goal is to deliver compassionate, high-quality care tailored to each individual’s needs.

Specialization and Expertise

Medical Gastroenterology

OPD Timings

MON
Not Available
TUE
Not Available
WED
Not Available
THU
Not Available
FRI
08:00 AM to 01:30 PM
SAT
Not Available
SUN
Not Available
MON
08:00 AM to 04:00 PM
TUE
Not Available
WED
Not Available
THU
Not Available
FRI
08:00 AM to 04:00 PM
SAT
Not Available
SUN
Not Available

Certifications

  1. Certified by Cornerstones Europe in the IBD Xcelerator Program.
  2. Member American College of Gastroenterology
  3. Member American Gastroenterological Association
  4. Member European Crohn’s and Colitis Organization
  5. Member Asian Organization for Crohn’s and Colitis
  6. Life Member Indian Society of Gastroenterology
  7. Life Member Association of Physicians of India
  8. Life Member Colitis and Crohn’s Foundation (India)
  9. Life Member Gastrointestinal Infection Society of India
  10. Life Member Society of Gastrointestinal Endoscopy of India 

Publications

  • Singh A, Luthra M, Bhardwaj A, et al. Clinical spectrum of acute severe ulcerative colitis in the biologic era: a prospective cohort study from India. Intest Res. Published online June 9, 2025. doi:10.5217/ir.2024.00189
  • Singh A, Bhardwaj A, Sharma R, Midha V, Sood A. Developing IBD counsellors in low- and middle-income countries: bridging gaps in patient care. eClinicalMedicine, Volume 83, 103218
  • Singh A, Bhardwaj A, Sharma R, Jain D, Midha V, Sood A. Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis. Clin Gastroenterol Hepatol. Published online April 15, 2025. doi:10.1016/j.cgh.2025.01.036
  • Singh A, Midha V, Sood A. Perspectives on the International Consensus for Acute Severe Ulcerative Colitis Clinical Trial Design: Enhancing Clarity and Applicability. Clin Gastroenterol Hepatol. Published online March 13, 2025. doi:10.1016/j.cgh.2024.12.034
  • Kakkar C, Bonaffini PA, Singh A, et al. MR enterography in Crohns disease and beyond: a pictorial review : Beyond Crohn's: a pictorial guide to MR enterography in small bowel disease. AbdomRadiol (NY). Published online February 3, 2025. doi:10.1007/s00261-025-04824-z
  • Singh A, Bhardwaj A, Midha V, Sood A. Microbiome testing in clinical practice. Lancet Gastroenterol Hepatol. 2025;10(5):414. doi:10.1016/S2468-1253(24)00432-1
  • Singh A, Bhardwaj A, Sharma R, et al. Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis. Intest Res. Published online November 11, 2024. doi:10.5217/ir.2024.00068
  • Singh A, Pandita RM, Goyal MK, Dhillon BK, Midha V, Sood A. Decoding genetic divergence: TPMT and NUDT15 polymorphisms in north India mirror Caucasian ancestry. Intest Res. 2025 May 19. doi: 10.5217/ir.2024.00027. Epub ahead of print. PMID: 40383916.
  • Singh A, Goyal MK, Midha V, et al. Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial. Am J Gastroenterol. Published online January 22, 2024. doi:10.14309/ajg.0000000000002635
  • Singh A, Midha V, Kaur K, et al. Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study. J Crohns Colitis. 2024;18(2):300-307. doi:10.1093/ecco-jcc/jjad153

Awards

  • Second Prize, Plenary Session, ISGCON 2024 (National Conference of the Indian Society of Gastroenterology), Varanasi, December 2024.
  • Best Review Article Award for the publication: Singh A, Wall C, Levine A, Midha V, Mahajan R, Sood A. Nutritional screening and assessment in inflammatory bowel disease. Indian J Gastroenterol. 2022, awarded at ISGCON 2024.
  • First Prize, Plenary Session, 8th National IBD Meet of Colitis and Crohn’s Foundation (India), Vizag, October 2024.
  • Distinguished Investigator Award, Annual Meeting of the Asian Organization for Crohn’s and Colitis (AOCC), Busan, South Korea, April 2023.
  • Second Prize, Plenary Session, ISGCON 2022 (National Conference of the Indian Society of Gastroenterology), Jaipur, January 2023.
  • Featured in the book Shining Sikh Youth of India.
  • Best Abstract Award, Annual Meeting of the Asian Organization for Crohn’s and Colitis (AOCC), Busan, South Korea.
  • Recommended for the Young Doctors Program, Asian Organization for Crohn’s and Colitis (AOCC) 2017, Seoul, South Korea.
logo

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...